Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma, microneedling with minoxidil, and topical finasteride are promising treatments for hair loss.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

Platelet-rich plasma may improve hair transplant results.

Gut bacteria pathways may help treat hair loss in obese people.

The new microneedle treatment effectively promotes hair growth better than minoxidil.

Targeting the TNFRSF1B gene may help treat hair loss.

Thyroid receptor β can help develop new drugs to treat hair loss.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

The study aims to find the most effective treatments for male pattern baldness.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

Obesity is linked to more severe hair loss in adult men and to excess hair growth, but its effects on hair conditions are complex and need more research.

Untreated androgenetic alopecia leads to progressive hair loss in men.

A man's scalp hair loss was due to a combined melanocytic nevus and alopecia areata, suggesting a possible link between the two conditions.

Older adults often have skin problems due to aging, and treating these conditions requires attention to both physical and mental health.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Certain genetic markers can indicate a person's risk of developing prostate cancer.

Accurate diagnosis and treatment of skin and hair disorders are crucial, with growing focus on hair loss treatments like topical minoxidil.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

Finasteride use linked to increased suicidality in patients under 45.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

Hair disease research is a growing and evolving field in dermatology, with recent significant advances.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Smoking and lighter hair color increase alopecia risk, especially in women and those over 25.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.